IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
2.330
-0.060 (-2.51%)
At close: Oct 6, 2025, 4:00 PM EDT
2.350
+0.020 (0.86%)
After-hours: Oct 6, 2025, 4:10 PM EDT
IN8bio Market Cap
IN8bio has a market cap or net worth of $10.58 million as of October 6, 2025. Its market cap has decreased by -31.49% in one year.
Market Cap
10.58M
Enterprise Value
787.32K
1-Year Change
-31.49%
Ranking
Category
Stock Price
$2.33
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $10.58M, a decrease of -94.36%. That is a compound annual growth rate of -49.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 10.85M | -41.80% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |